By Galen Care Partners on Friday, 01 December 2017
Category: Galen Care Partners News

Cytoreductive Nephrectomy Improves Survival in mRCC

Propensity score matching showed a 5.8 month survival advantage for initial CN vs initial systematic therapy.
Original link
Leave Comments